Showing results (1871-1880 of 2,028) with videos related to
Sort By:
Pageof 203
Neuro-Oncology|December 6, 2013
MDA-9/syntenin is a key regulator of glioma pathogenesisTimothy P Kegelman, Swadesh K Das, Bin Hu, et al.Molecular Pharmacology|November 14, 2009
Cisplatin enhances protein kinase R-like endoplasmic reticulum kinase- and CD95-dependent melanoma differentiation-associated gene-7/interleukin-24-induced killing in ovarian carcinoma cellsAdly Yacoub, Renyan Liu, Margaret A Park, et al.Cell Reports|June 15, 2022
Human peroxiredoxin 6 is essential for malaria parasites and provides a host-based drug targetMatthias Paulus Wagner, Pauline Formaglio, Olivier Gorgette, et al.Discovery Medicine|February 1, 2011
Developing an effective gene therapy for prostate cancer: New technologies with potential to translate from the laboratory into the clinicRupesh Dash, Belal Azab, Xue-Ning Shen, et al.World Journal of Surgery|October 4, 2022
Parathyroidectomy for Normocalcemic Primary Hyperparathyroidism is Associated with Improved Bone Mineral Density Regardless of Postoperative Parathyroid Hormone LevelsMichael S Lui, Uriel Clemente-Gutierrez, Danica M Vodopivec, et al.The Diabetes Educator|February 3, 2007
The Robert Wood Johnson Foundation Diabetes Initiative: demonstration projects emphasizing self-managementEdwin B Fisher, Carol A Brownson, Mary L O'Toole, et al.Cancer Research|May 31, 2011
Sorafenib enhances pemetrexed cytotoxicity through an autophagy-dependent mechanism in cancer cellsM Danielle Bareford, Margaret A Park, Adly Yacoub, et al.Proceedings of the National Academy of Sciences of the United States of America|April 27, 2016
Warm spring reduced carbon cycle impact of the 2012 US summer droughtSebastian Wolf, Trevor F Keenan, Joshua B Fisher, et al.Journal of Surgical Oncology|December 19, 2013
Transplant versus resection for the management of hepatocellular carcinoma meeting Milan Criteria in the MELD exception era at a single institution in a UNOS region with short wait timesMalcolm H Squires, Steven I Hanish, Sarah B Fisher, et al.Cancer Letters|December 28, 2016
Somatostatin receptor targeted liposomes with Diacerein inhibit IL-6 for breast cancer therapyRashmi Bharti, Goutam Dey, Indranil Banerjee, et al.Pageof 203